Prévisions du marché nord-américain du diagnostic du cancer du cerveau jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type de diagnostic (test d’imagerie, ponction lombaire, biopsie, tests moléculaires et autres) ; Type de cancer (névrome acoustique, astrocytome, craniopharyngiomes, ganglioneuromes, glioblastome multiforme, méningiomes, épendymomes et autres) ; Utilisateur final (hôpitaux, cliniques spécialisées, centres chirurgicaux ambulatoires et autres)

Introduction au marché

Les cancers du cerveau sont dus à la croissance extracellulaire des cellules du cerveau qui provoquent des tumeurs. La tumeur comprend les tumeurs cérébrales primaires et les tumeurs cérébrales secondaires. Les tumeurs cérébrales primaires se forment dans le cerveau et ne se propagent pas à d\'autres parties du corps, tandis que les tumeurs secondaires, également appelées métastases, sont des cancers qui ont commencé dans une autre partie du corps. Les tumeurs cérébrales sont classées en 40 types principaux, eux-mêmes classés en deux grands groupes : bénins, c\'est-à-dire à croissance lente et ayant moins de chance de se propager, et malins, c\'est-à-dire cancéreux et plus susceptibles de se propager.

< p>Ainsi, l\'augmentation de la prévalence du cancer du cerveau devrait créer une demande importante de diagnostics du cancer du cerveau dans les années à venir, ce qui devrait en outre stimuler le marché du diagnostic du cancer du cerveau.

Le COVID-19 La pandémie a perturbé les systèmes de santé, ce qui suscite des inquiétudes quant à son impact ultérieur sur les pathologies non liées à la COVID. Le diagnostic et le traitement du cancer sont sensibles au facteur temps et sont susceptibles d\'être considérablement affectés par ces conditions. Les activités de chaque discipline du cancer ont été affectées par la pandémie de COVID-19. De plus, les tumeurs cérébrales malignes de l’enfant se caractérisent par une croissance rapide et nécessitent un diagnostic précoce et un traitement approprié. Par conséquent, retarder ou modifier le traitement peut compromettre son efficacité et réduire la survie des patients. Florès et coll. ont rapporté qu\'un diagnostic tardif des tumeurs cérébrales est corrélé à un pire pronostic. Un intervalle symptomatique pré-diagnostique prolongé a des conséquences négatives et graves, telles que la mort ou des lésions cérébrales graves suite à l\'augmentation de la pression intracrânienne. En raison de la peur et de la pression liées à l’infection par le SRAS CoV2, les changements dans le processus décisionnel des enfants atteints de tumeurs cérébrales peuvent avoir un impact négatif sur leur résultat final. Les comités multidisciplinaires des tumeurs n’ont jamais joué un rôle crucial lors de l’épidémie actuelle de COVID-19. Tous les cas pédiatriques diagnostiqués avec une nouvelle tumeur cérébrale doivent être discutés au sein du comité multidisciplinaire des tumeurs afin de déterminer le meilleur plan de traitement pour chaque enfant.

Aperçu et dynamique du marché

Le marché du diagnostic du cancer du cerveau en Amérique du Nord devrait passer de 301,5 millions de dollars américains en 2021 à 911,0 millions de dollars d’ici 2028 ; on estime qu\'il augmentera à un TCAC de 17,1 % de 2021 à 2028. Les chercheurs ont souligné que la capacité de la technologie de l\'intelligence artificielle et des pathologistes à se vérifier mutuellement met en évidence la nécessité pour les pathologistes de coopérer avec la technologie de l\'intelligence artificielle pour interpréter les cas difficiles et garantir la plus grande précision de diagnostic possible. Aujourd\'hui, plusieurs grands centres de cancérologie aux États-Unis utilisent des imageurs SRH. L’imagerie SSR et IA sont des technologies émergentes, leur intégration dans les soins de santé sera donc un défi. La technologie de l’IA permet aux chirurgiens d’identifier rapidement et précisément les zones contenant des tumeurs ou des tissus sains. Ainsi, l\'intelligence artificielle SSR est de plus en plus utilisée pour améliorer le diagnostic des tumeurs cérébrales pendant la chirurgie.

Segments clés du marché

En termes de type de diagnostic, le segment des tests d\'imagerie représentait la plus grande part du marché nord-américain du diagnostic du cancer du cerveau en 2020. En termes de type de cancer, le segment du glioblastome multiforme représentait la plus grande part du marché nord-américain du diagnostic du cancer du cerveau. part du marché nord-américain du diagnostic du cancer du cerveau en 2020. En termes d\'utilisateurs finaux, le segment des hôpitaux représentait la plus grande part du marché nord-américain du diagnostic du cancer du cerveau en 2020.

Principales sources et entreprises répertoriées

Quelques principales sources primaires et secondaires Les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents gouvernementaux nationaux et les bases de données statistiques sont, entre autres, mentionnés pour la préparation de ce rapport sur le marché du diagnostic du cancer du cerveau en Amérique du Nord. Les principales sociétés répertoriées dans le rapport sont Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. et Neusoft Medical Systems.

Rapport sur les raisons d\'acheter

Comprendre le paysage du marché nord-américain du diagnostic du cancer du cerveau et identifier les segments de marché les plus pertinents. susceptible de garantir un rendement solide
Gardez une longueur d\'avance en comprenant le paysage concurrentiel en constante évolution du marché nord-américain du diagnostic du cancer du cerveau
Planifiez efficacement les fusions et acquisitions et les accords de partenariat en Amérique du Nord. Marché américain du diagnostic du cancer du cerveau en identifiant les segments de marché avec les ventes probables les plus prometteuses
Aide à prendre des décisions commerciales éclairées grâce à une analyse perspicace et complète des performances du marché de divers segments du marché nord-américain du diagnostic du cancer du cerveau
Obtenez les prévisions de revenus du marché pour différents segments de 2021 à 2028 dans la région Amérique du Nord.

Segmentation du marché nord-américain du diagnostic du cancer du cerveau

Par type de diagnostic

< ul>

Test d\'imagerie

IRM
CT Scan
PET

Biopsie

Tests moléculaires

Ponction lombaire

Autres

Par type de cancer

Glioblastome multiforme
Astrocytomes
Épendymomes
Autres

Par Utilisateur final

Hôpitaux
Cliniques spécialisées
Centres de chirurgie ambulatoire
Autres

Par pays

Amérique du Nord
- États-Unis
- Canada
- Mexique

Entreprises mentionnées

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 North America Brain Cancer Diagnostics Market – By Country

2. North America Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – North America Analysis

6.1 North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.3.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.4 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.5.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MDxHealth

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NantOmics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Biocept, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Koninklijke Philips N.V.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Canon Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Hitachi, Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Neusoft Medical Systems

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Brain Cancer Diagnostics Market

Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. North America Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - North America PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample